Skip to main content
. 2019 Sep 2;2019(9):CD004421. doi: 10.1002/14651858.CD004421.pub3

Comparison 2. Type of taxane.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Overall survival 27   Hazard Ratio (95% CI) Subtotals only
1.1 Docetaxel 15 22105 Hazard Ratio (95% CI) 0.86 [0.81, 0.92]
1.2 Paclitaxel 12 17075 Hazard Ratio (95% CI) 0.89 [0.82, 0.96]
2 Disease‐free survival 30   Hazard Ratio (95% CI) Subtotals only
2.1 Docetaxel 16 22730 Hazard Ratio (95% CI) 0.87 [0.82, 0.91]
2.2 Paclitaxel 14 19179 Hazard Ratio (95% CI) 0.91 [0.85, 0.96]